Asia Pacific | Singapore

HiFi Sequencing Experience Tour

 8 May 2023
 9:00am to 1:00pm
 20 Science Park Rd Singapore Science Park 2, 117674 | Teletech Park Conference Room (Level 1, behind the Customer Service Counter)

Join us on 8 May 2023 as the PacBio HiFi Sequencing Experience Tour Roadshow Event is back in Singapore for its second consecutive year. Discover how HiFi sequencing is helping scientists find accurate and actionable genome-wide insights for the most important scientific discoveries.

There will be presentations by industry-leading scientists and the opportunity for peer-to-peer discussions and networking during this event. Whether you have a single sample or a multi-genome project, complete and accurate long-read sequencing is designed to support your desire to make an impact.  

We look forward to meeting you in person.


Transportation Access:

1. Driving: There are ample parking lots available within Teletech Park.

2. Public Transport:

  • Bus no. 183 is located conveniently in front of the building
  • 5 minutes walk to the bus stop with bus service nos. 10, 30, 51, 143, 188 & 200
  • 10 minutes walk to Haw Par Villa MRT station

3. Private Hire: You may consider private hire options such as ComfortDelGro, Grab, Gojek, TADA, Ryde, etc.

4. Chartered Bus:

We also offer chartered bus services with the following schedule:

  • 8:40 am: From Haw Par Villa MRT station to Teletech Park
  • 1:15 pm: From Teletech Park to Haw Par Villa MRT station

Highlights include:

  • The opportunity to connect with and hear from your peers
  • Immerse yourself in rich scientific content from across the Plant & Animal, Human, Rare & Inherited Diseases and Microbial genomics segments
  • Learn how to take full advantage of your samples and the PacBio HiFi advantage

Singapore | HiFi Sequencing Experience Tour Event | 8 May 2023 | 9:00am-1:00pm

8:30am Registrations All
9:00am Welcome & Introduction Lyndsey Lam
9:05am PacBio: Changing the Sequencing Game Jennifer Hsu
9:15am Human Genomics  Edd Lee
9:35am A new age in cancer genomics research: from single-cell transcriptomics to liquid biopsy Alex Sockell (virtual)
9:50am Deciphering the glial function of TDP-43 Shuo-Chien Ling
10:20am Coffee break  
10:30am Microbial Metagenome Updates Khi Pin Chua
10:45am Not all telomeres are equal: allele-specific telomere length measurement in aging-associated diseases Dr. Shang Li
11:15am Increased Diagnostic Yield With Long Read Sequencing In Patients With Undiagnosed Neurodevelopmental Disorder Dr. Saumya Shekhar Jamuar
11:45am Long-read Capture with Twist Target Enrichment System  Nicole Lee (Twist)
11:55am HiFi approach to targeted sequencing Zuwei Qian
12:10am Customer Speaker 4  
12:15pm Lunch / Revio Demonstration at SG Apps Lab All / Service & Support Team


By registering on this web page, you are consenting and agreeing to collection and use of that information by PacBio in accordance with its Privacy Policy.


Edd Lee, PhD

Director, Human Genomics Segment Marketing

Alex Sockell, PhD

Marketing Manager, Oncology and Cancer Research

Zuwei Qian, PhD

Director of Marketing, Asia Pacific

Dr. Saumya Shekhar Jamuar, MBBS, MRCPCH (UK), FAMS, FACMG

Senior Consultant, Genetics service, Dept of Paediatrics; Deputy Director (Clinical)
KK Women's and Children's Hospital; SingHealth Duke-NUS Institute of Precision Medicine

Dr. Shang Li, MBBS, PhD

Associate Professor, Cancer and Stem Cell Biology; Director of NCRIS CRISPR core facility
Duke-NUS medical School

Shuo-Chien Ling, PhD

Associate Professor, Department of Physiology
NUS, Yong Loo Lin School of Medicine, Laboratory for Molecular Neurodegeneration


Shuo-Chien Ling, Ph.D.
Associate Professor, Department of Physiology
NUS, Yong Loo Lin School of Medicine, Laboratory for Molecular Neurodegeneration

My research investigates both fundamental and translational aspects of neuroscience combining multiple techniques and disciplines focusing on two major areas: mechanisms underlying molecular basis for synaptic plasticity and adult-onset neurodegenerative diseases. In particular, we elucidate gene-function relationships using disease-causing genes, including fragile X mental retardation protein (FMRP), TDP-43 (TAR-DNA binding protein-43 KDa), FUS/TLS (fused in sarcoma/translocated in liposarcoma), and C9ORF72 (chromosome 9 open reading frame 72).

During my undergraduate study in Chemical Engineering, I became fascinated in biology, particularly, neuroscience. After obtaining BSc and MSc at the National Tsing-Hua University (NTHU), Taiwan, I went on to complete my Ph.D. (2005) at the Neuroscience program at the University of Illinois at Urbana-Champaign, USA under Professors William Greenough and Vladimir Gelfand. After a short postdoc at Northwestern University, I moved to University of California, San Diego (UCSD) with Professor Don W. Cleveland. At October 2013, I started my group at the National University of Singapore (NUS), and promoted to Associate Professor at 2022.



Dr. Saumya Shekhar Jamuar, MBBS, MRCPCH (UK), FAMS, FACMG
Senior Consultant, Genetics service, Dept of Paediatrics; Deputy Director (Clinical)
KK Women's and Children's Hospital; SingHealth Duke-NUS Institute of Precision Medicine

Dr Saumya Jamuar is a Clinical Geneticist at KKH, serves as the Lead PI of the Singapore Childhood Undiagnosed Disease/ BRIDGES Programme and is the Clinical Director of the SingHealth Duke-NUS Institute of Precision Medicine. He was the Inaugural head of the SingHealth Duke-NUS Genomic Medicine Centre. He is the co-founder of Global Gene Corporation Pte Ltd.

He completed his Genetics Fellowship at Harvard Medical School. He is actively involved in research, has presented at both local and international meetings and has published in top tier journals including The New England Journal of Medicine and Nature Genetics. His research areas include rare genetic disorders, dysmorphology, skeletal dysplasia, and neurodevelopmental genetics. He was awarded the Young Investigator Award at the 2013 American Epilepsy Society meeting and is the recipient of the 2015 Singhealth Outstanding Young Researcher Award, Singhealth Outstanding Publish Award, and 2021 National Medical Research Council Clinician Scientist Award.


Dr. Shang Li, MBBS, PhD
Associate Professor, Cancer and Stem Cell Biology; Director of NCRIS CRISPR core facility
Duke-NUS Medical School

Dr. Shang Li is currently an Associate Professor in the Cancer and Stem Cell Biology program at Duke-NUS medical School. He obtained his MBBS degree from Beijing Medical University (Peking University, School of Medicine). He obtained his Ph.D. degree in Molecular Medicine from UTHSCSA under the supervision of Dr. WenHwa Lee (Member, Sinica Academia, ROC). For his postdoctoral training, he joined Dr. Elizabeth Blackburn’s laboratory at University of California San Francisco (UCSF). Dr. Blackburn was awarded the Nobel Prize in Physiology or Medicine in 2009 for her discovery of “how chromosomes are protected by telomeres and the enzyme telomerase”. He joined Duke-NUS Medical School since 2010. His lab focuses on the regulation of telomerase in human cancer cells and normal stem cells to develop therapeutic interventions for human cancer and aging. Dr. Li is also the director of NCRIS CRISPR core facility that provides service to research communities at Duke-NUS Medical School and NCCs. He has published over 50 papers and book chapters including: Nature, Science, Cell, Molecular Cell, Nature Cell Biology, Cancer Discovery, Nature Comm. etc. (h-index=28, i10-index=38).

background-image: none

Follow our roadshow on social media